Meningococcal Vaccines Market’s Growth at 8.6% CAGR,...

added article Health

Meningococcal Vaccines Market’s Growth at 8.6% CAGR, Envisioning US$ 7.7 Billion in 2032

Over the forecast period, the market for meningococcal vaccines is anticipated to grow at a CAGR of 8.6%, reaching US$ 3.4 Bn in 2022. According to Future Market Insights (FMI), the conjugate vaccines segment held a 62.6% revenue share of the market in 2021. The global meningococcal vaccines market is expected to grow at an 8.6% CAGR during the forecast period, reaching US$ 3.4...

0 Comments 0 Shares